“An anti-ERBB2 mono clonal antibody 4D5, which was later humanized to generate trastuzumab, was … inhibitory effect on ERBB2overexpressing breast cancer cells.6 Growing evidence indicates that targeting ERBB2 using trastuzumab … tyrosine phosphorylation in trastuzumab-sensitive breast cancer cells.7–…-sensitive breast Trastuzumab is not a tyrosine kinase inhibitor”